HCD122
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for HCD122, covering 2012-10-01 to 2020-12-17. Get the full timeline:
Most recent: Clinical Trial Update: Study of HCD122 in Adults With Non-Hodgkin's or Hodgkin's Lymphoma Who Have Progressed After at Least Two Prior Therapies [Phase 1, Phase 2]